Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 5, 2021, after the close
10-Q filed May 6, 2021, 36 days after period end · 0001564590-21-024268
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $106.55M | $90.07M | $62.96M | $48.87M |
| Net Income | -$66.45M | -$88.02M | -$85.30M | -$54.30M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.42 |
| -$0.57 |
| -$0.59 |
| -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
